Clinigen

Activities: Regulatory

Trending Articles

  1. Scleroderma treatment by Certa Therapeutics granted US FDA fast track FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Indian government bans three medicines owing to health risks Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
  4. Dickson achieves ISO 14001 certification ISO 14001 certification highlights a companies' long-term efforts to manage its environmental impact
  5. The key role of IVDs in healthcare: challenges to commercialisation and access In simple terms, in vitro diagnostic (IVD) tests are done on samples such as blood or tissue that have been taken from the human body. IVDs can detect diseases, conditions and...

Upcoming event

Interphex

16-18 April 2024 | Conference and Exhibition | New York, US See all

Related Content

Finance

Clinigen expands Accord partnership into France

Earlier this year, Clinigen’s Global Access Business also extended its partnership with Accord for a further five years
Manufacturing

Porton Biopharma Limited licenses Erwinase to Clinigen

The new contract with Clinigen will begin on 1 January 2021
Packaging

Packaging for success

Somewhat misguidedly, pharmaceutical packaging is often overlooked or assumed to be a commodity service that “anyone can do,” says Scott Houlton, CEO, CSM (a Clinigen Group company)
Media

Clinigen strengthens senior management team

Media

Clinigen acquires Japan’s largest supplier of unlicensed medicines

Clinigen Group, a global pharmaceutical and services company, has acquired International Medical Management Corporation, Japan’s largest supplier of unlicensed medicines, for an undisclosed sum

AI and CAH patients can access unlicensed medicines

Clinigen and Diurnal partner up for European Managed Access programme for Infacort and Chronocort
Distribution

Clinigen and BTG extend global partnership with new exclusive Global Access agreement

Agreement extends the 4-year partnership Clinigen has with BTG to provide early access programmes
Subscribe now